Neogen Corporation Proceeds from Long-Term Debt Issued
Neogen Corporation (NEOG) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-07-30
- Neogen Corporation proceeds from issuance of long-term debt for fiscal 2026 was $0.00, a 100.00% decline from fiscal 2025.
- Neogen Corporation proceeds from issuance of long-term debt for fiscal 2025 was $450.00M.
- Neogen Corporation proceeds from issuance of long-term debt for fiscal 2024 was $0.00.
- Neogen Corporation proceeds from issuance of long-term debt for fiscal 2023 was $0.00.
| Period end | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|
| 2026-05-31 | $0.00 10-K · filed 2026-07-30 |
| 2025-05-31 | $450.00M 10-K · filed 2026-07-30 |
| 2024-05-31 | $0.00 10-K · filed 2026-07-30 |
| 2023-05-31 | $0.00 10-K · filed 2025-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |